Lee, J., Hasegawa, K., Kim, B., Berman, B. S., Suzuki, S., Corr, B., Yunokawa, M., Orr, D., Yamamoto, N., Soliman, P. T., Miller, D. S., Sahara, T., Dutta, L., Wu, J., McKenzie, J., Makker, V. (2025). E7386 study 102: Global dose-expansion cohort of E7386 + lenvatinib (LEN) in patients (pts) with advanced endometrial cancer (aEC) that progressed on platinum-based chemotherapy (chemo) and an anti-PD-(L)1 immunotherapy (IO).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5599